KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) EPS (Weighted Average and Diluted) (2016 - 2025)

Elevance Health (ELV) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $2.54 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 35.83% to $2.54 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.19 through Dec 2025, down 1.87% year-over-year, with the annual reading at $25.21 for FY2025, 1.83% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.54 at Elevance Health, down from $5.32 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $9.85 in Q2 2024, with the low at $1.87 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $6.26, with a median of $6.66 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 604.6% in 2021, then crashed 48.91% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $4.86 in 2021, then dropped by 25.72% to $3.61 in 2022, then increased by 1.39% to $3.66 in 2023, then plummeted by 48.91% to $1.87 in 2024, then skyrocketed by 35.83% to $2.54 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $2.54, $5.32, and $7.72 for Q4 2025, Q3 2025, and Q2 2025 respectively.